2026年3月26日，Kodiak Sciences宣布VEGF抗体聚合物Zenkuda治疗糖尿病性视网膜病变（DR）的三期临床GLOW2获得硬性结果。 受此消息影响，Kodiak Sciences当天股价大涨75%，市值达到24.6亿美元。

Investing.com -- Wave Life Sciences Ltd. (NASDAQ:WVE)股价周四下跌30%,此前该公司公布了其INLIGHT试验的中期1期数据,该试验正在评估WVE-007用于肥胖症治疗的效果。 Wave Life ...

近日，大橡科技凭借在类器官芯片领域的技术创新与服务能力，荣获国际权威杂志《Life Sciences ...

Investing.com - 奥本海默在Wave Life Sciences(NASDAQ:WVE)公司公布其1期INLIGHT研究的临床更新后,重申了其跑赢大盘评级和32.00美元的目标价。该目标价相较当前12.30美元的股价显示出上涨潜力,不过InvestingPro数据显示,根据其公允价值分析,该股票目前的估值可能偏高。 该研究评估了WVE-007,其中240毫克剂量组在六个月时显示内脏脂 ...

生命科学Life science在Trends in Biochemical Sciences创刊五十周年这个特别的时间节点，回顾本刊的创刊初衷与目标，令我倍受启发。1976年首期Trends in Biochemical ...

SHANGHAI, March 21 (Xinhua) -- China on Saturday published a high-quality journal list in the fields of medicine and life sciences, independently compiled by domestic institutions, offering a Chinese ...

Abbott closes $21B acquisition of Exact Sciences (EXAS) at $105/share. EXAS delisted from Nasdaq on March 23, 2026, becoming ...

Q4 2025 Earnings Call March 26, 2026 4:30 PM EDTCompany ParticipantsBrendan Hawkins - Investor RelationsJoseph Dowling - ...

Wave Life Sciences shares plunged >50% after Phase 1 INLIGHT data for WVE-007 showed <1% placebo-adjusted weight loss at six ...

Joel Mokyr, Philippe Aghion and Peter Howitt have been awarded the 2025 Nobel Prize in Economics. (Photo by Jonathan Nackstrand / AFP) / ALTERNATIVE CROP (Photo by JONATHAN NACKSTRAND/AFP via Getty ...